Press Release
Aug 16, 2019
DENVER – Paul Brown, a lung cancer survivor from Prospect, Australia, will be recognized by the International Association for the Study of Lung Cancer (IASLC) at the IASLC 2019 World Conference on Lung Cancer (WCLC) in Barcelona, Spain. Brown will accept the Advocate Travel Award, which is given to five individuals to help them attend and participate in the IASLC WCLC.
Brown is an advocate for Rare Cancers Australia (RCA) and has raised over A$90,000 for RCA by hosting two dinner auctions for friends, work colleagues and finance industry professionals. He is a lung cancer survivor currently on a drug trial that restricts his medical and traveling expenses. As an Advocate Travel Award recipient, Brown will be able to attend the IASLC WCLC to further his advocacy efforts.
Brown is always seeking information about the latest procedures, medications and advancements in patient care. Seeing and hearing the success stories of lung cancer patients at the WCLC who are living an average of five to 10 years longer gives him hope and boosts his personal prognosis. With Brown attending the WCLC, he will be able to bring back this information to Australia and break the stigma that lung cancer is only caused through smoking.
After attending the WCLC, Brown hopes to build a stronger fundraising team for RCA’s Kosi 2020 event, a challenge for participants to climb Australia’s highest peak to raise funds for, and awareness of, rare cancers. He also hopes to shed more light on the annual lung cancer walk through the media.
“By the time I return from the conference, I will be only two months short of my five-year mark of cancer survivorship. This is a huge milestone rarely achieved in times past but is becoming more commonplace and a powerful marker when sharing statistics and information,” says Brown.
As an Advocate Travel Award recipient, Brown will receive complimentary conference registration, a fixed monetary stipend to help offset travel costs, four nights’ accommodation at one of the conference contracted hotels and free IASLC membership for 2020, allowing him to continue his lung cancer education and advocacy work.
About the WCLC:
The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit wclc2019.iaslc.org.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.